<DOC>
	<DOC>NCT00673751</DOC>
	<brief_summary>The aim of the study is to investigate the effect of the enteric hormone Glucagon-like Peptide (GLP-2) on patients with short bowel syndrome</brief_summary>
	<brief_title>Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome</brief_title>
	<detailed_description>previous studies have shown that GLP-2 increases mesenteric blow flow, we wish to examine the effect of subcutaneus GLP-2 on patients with short bowl syndrome. The patients will single blinded been given 450 nmol GLP-2 and isotonic saline in order to act as their own reference.</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Short Bowel Syndrome</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>clinical diagnose of short bowel syndrome 4 month of stable fase activity in IBD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>mesenteric blood flow</keyword>
	<keyword>GLP-2</keyword>
	<keyword>short bowel syndrome</keyword>
	<keyword>Glucagon-Like Peptide 2</keyword>
</DOC>